Varicose Vein Treatment Devices Market (By Treatment Type: Injection Sclerotherapy, Endovenous Ablation, and Surgical Ligation/Stripping; By Product: Surgical Products, Venous Closure Products, and Ablation Device) - Global Industry Analysis, Market Size, Opportunities, and Forecast 2021 - 2028

The global varicose vein treatment devices market is anticipated to grow at a CAGR of around 6.9% during the forecast period 2021 to 2028 and to reach around US$ 1,812.6 Million by 2028.

Report coverage

Market Dynamics

Varicose veins, also known as varicosities or varicoses, are a vein expansion disorder. The veins in this disease are blue or dark purple in colour and enlarged. A varicose patient may experience discomfort as a result of the obstructed blood flow. Because standing and walking increase the pressure in the veins of the lower body, the disease is most commonly seen in the legs and feet.

The market for varicose vein treatment devices is expected to grow in the coming years for a variety of reasons, including an increase in the rising obesity rates, prevalence of varicose veins, and deep vein thrombosis, which can lead to ulcers and blood clots. Purple or dark blue veins, bulging or twisting veins, leg ache, itching, and discomfort that worsens after prolonged standing or sitting are all signs of varicose veins. Varicose veins can be quite unsightly. They only become a problem when they cause pain, aching, swelling, and significant discomfort. In severe cases, they may burst, resulting in ulcers. Treatment options for this disease have advanced significantly in recent years. The vast majority of private healthcare providers now provide advanced minimally invasive procedures.

Varicose veins are more common in older people. Aging has a significant impact on the veins' shape and function. Varicose veins affect one out of every two people over the age of 50. Overweight or pregnant women are also at risk of contracting this disease. Sclerotherapy, laser therapy, and radiofrequency ablation are just a few of the treatments available. Sclerotherapy is the treatment of choice for varicose, spider, and reticular veins.

In the near future, surgical treatments for varicose veins are expected to undergo significant changes. Noninvasive procedures have largely replaced surgery. In recent years, the desire for noninvasive procedures has grown as the risk of infection associated with invasive procedures has increased. This factor is expected to boost the varicose veins treatment devices market during the forecast period.

Aside from the risk of infection, noninvasive techniques necessitate shorter hospital stays, saving both time and money. Foam sclerotherapy, endovenous laser treatment, and radiofrequency ablation are being used by more surgeons in place of more traditional surgical procedures.

Segment Analysis By Region

North America projected to be the region with the fastest growing demand for varicose vein therapy devices. This is usually due to the early adoption of cutting-edge technology and evidence of the safety and efficacy of laser therapies. On the contrary, Asia Pacific is rapidly gaining traction as disposable income rises. In December 2019, Leucadia Pharmaceuticals released a generic version of Sodium Tetradecyl Sulfate (STS), a sclerosing agent approved by the US Food and Drug Administration for the treatment of minor varicose veins in the lower legs.

Along with treating the symptoms and appearance of your varicose vein, certain medical facilities are also addressing the underlying cause of this problem. There are several theories about how to treat this disease successfully, but most doctors believe that the key to healing is to relieve pain in the affected limb and to remove the damaged blood vessels. Despite new product launches and advances in minimally invasive surgery technologies, some aspects of the industry continue to stymie future growth. For example, a lack of qualified people, particularly in developing countries, may typically stymie the growth of the varicose vein treatment devices market.

The most commonly used therapeutic options are sclerotherapy and laser treatment. The main difference between these two treatment methods is the frequency with which they are used. Sclerotherapy is only used to treat the largest varicose veins, whereas laser treatment is more commonly used to treat the smaller varicose veins. Diversifying product portfolios has become critical for market leaders looking to strengthen their market position. To accomplish this, these companies are focusing their efforts on the development of new and successful products. These factors may contribute to the growth of the varicose vein therapy devices market in the near future.

Competitive Landscape                                                                                                                   

The global Varicose Vein Treatment Devices market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Varicose Vein Treatment DevicesMarket Segment Analysis, 2020

The global Varicose Vein Treatment Devices market is segmented into treatment type, and product. The Treatment Type segment is divided into below surgical ligation/stripping, endovenous ablation, injection sclerotherapy. The product segment is bifurcated into surgical products, venous closure products, ablation device. Players operating in the global Varicose Vein Treatment Devices market are Key companies covered in the report are Teleflex Incorporated, Medtronic plc, Lumenis, Quanta System, Biolitec AG, Vascular Solutions InAngioDynamics, Inc., Syneron Medical Ltd, Biolitec AG.

Market Segmentation

Market By Treatment Type

• Injection Sclerotherapy
• Endovenous Ablation
• Surgical Ligation/Stripping

Market By Product

• Surgical Products
• Venous Closure Products
• Ablation Device

Market By Region

• North America
  • US 
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil 
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • South Africa
  • Rest of Middle East and Africa